In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Roche pays Agouron, Japan Tobacco $40mm for Viracept

Executive Summary

Roche agreed to pay Agouron and Japan Tobacco $40mm plus sales royalties for exclusive marketing rights to Viracept, an anti-HIV drug (nelfinavir mesylate), in Europe and territories outside North America, Japan and Asia.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies